Latest Breaking News On - Analyst recommendations for teva pharmaceutical industries - Page 1 : comparemela.com

Bank of America Boosts Teva Pharmaceutical Industries (NYSE:TEVA) Price Target to $21 00

Bank of America Boosts Teva Pharmaceutical Industries (NYSE:TEVA) Price Target to $21 00
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesMark sabagPiper sandlerAmir weissAnalyst recommendations for teva pharmaceutical industriesTeva pharmaceutical industries stock performanceNews ratings for teva pharmaceutical industries dailyIndustrial alliance investment management incGoldman sachs groupSecurities exchange commissionTeva pharmaceutical industriesJpmorgan chase coEntrypoint capitalBlue trust incCovenant trust companyGet free report

StockNews com Lowers Teva Pharmaceutical Industries (NYSE:TEVA) to Buy

StockNews.com cut shares of Teva Pharmaceutical Industries (NYSE:TEVA – Free Report) from a strong-buy rating to a buy rating in a research report released on Monday. A number of other research analysts have also recently weighed in on TEVA. The Goldman Sachs Group boosted their target price on shares of Teva Pharmaceutical Industries from $10.00 […]

Los angelesUnited statesNew zealand generalNew zealandAmir weissVikkil conwayPiper sandlerJefferies financial groupAnalyst recommendations for teva pharmaceutical industriesGateway investment advisersJpmorgan chase coTeva pharmaceutical industries company profileGoldman sachs groupTeva pharmaceutical industriesSg americas securitiesWellington management group

Teva Pharmaceutical Industries (NYSE:TEVA) Price Target Raised to $20 00

Teva Pharmaceutical Industries (NYSE:TEVA) Price Target Raised to $20 00
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesPiper sandlerRichardd francisMark sabagDekabank deutsche girozentraleDesjardins global asset management incGoldman sachs groupJpmorgan chase coSecurities exchange commissionInstitutional trading of teva pharmaceutical industriesOppenheimer coNews ratings for teva pharmaceutical industries dailyTeva pharmaceutical industries company profileTeva pharmaceutical industriesEdmond de rothschild holdingClarivest asset management

Teva Pharmaceutical Industries (NYSE:TEVA) Price Target Raised to $20 00 at Barclays

Teva Pharmaceutical Industries (NYSE:TEVA) Price Target Raised to $20 00 at Barclays
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

United statesMark sabagRichardd francisPiper sandlerInstitutional trading of teva pharmaceutical industriesTeva pharmaceutical industries price performanceGoldman sachs groupNews ratings for teva pharmaceutical industries dailyJpmorgan chase coJefferies financial groupAnalyst recommendations for teva pharmaceutical industriesBlue trust incNewbridge financial services group incSecurities exchange commissionDesjardins global asset management incTeva pharmaceutical industries

Barclays Increases Teva Pharmaceutical Industries (NYSE:TEVA) Price Target to $20 00

Barclays Increases Teva Pharmaceutical Industries (NYSE:TEVA) Price Target to $20 00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesMark sabagPiper sandlerDekabank deutsche girozentraleEdmond de rothschild holdingTeva pharmaceutical industries company profileTeva pharmaceutical industries stock performanceAnalyst recommendations for teva pharmaceutical industriesJpmorgan chase coTeva pharmaceutical industriesJefferies financial groupClarivest asset managementDesjardins global asset management incOppenheimer coNews ratings for teva pharmaceutical industries dailyGoldman sachs group